Radiological Imaging for Median Arcuate Ligament Syndrome (MALS)
CT angiography (CTA) of the abdomen and pelvis is the recommended first-line imaging modality for diagnosing Median Arcuate Ligament Syndrome (MALS), followed by mesenteric angiography in lateral projection during both inspiration and expiration to confirm the diagnosis if needed. 1
Initial Diagnostic Imaging
CT Angiography (CTA)
- CTA provides the highest accuracy and inter-reader agreement for grading mesenteric vessel stenosis with sensitivity and specificity of 95-100% 2
- Key findings on CTA include:
- CTA should be performed during both inspiratory and expiratory phases to demonstrate dynamic compression 1
Confirmatory Imaging
If CTA findings suggest MALS, the following may be used for confirmation:
Mesenteric Angiography:
- Performed in lateral projection during both inspiration and expiration 2
- Rated 7/9 (usually appropriate) by the American College of Radiology 2
- Documents dynamic worsening of stenosis during expiration 1
- Identifies mesenteric collateralization, which helps predict surgical outcomes 2
- Patients with collateralization on angiography are less likely to benefit from surgical release 2
Duplex Doppler Ultrasound:
- Useful as a screening tool and for follow-up 2
- Best performed in fasting state to avoid bowel gas 2
- Peak systolic velocity cutoffs for stenosis:
- SMA: 295 cm/s for 50% stenosis, 400 cm/s for 70% stenosis
- Celiac artery: 240 cm/s for 70% stenosis 2
- Can demonstrate respiratory variation in celiac artery flow 6
Diagnostic Criteria
- Stenosis >30% is considered the threshold for intervention 1
- Fold angle (FA) measurement is important:
Post-Treatment Imaging
- Duplex ultrasound or CTA at 6 months and annually thereafter to assess:
Clinical Pitfalls and Considerations
Incidental findings vs. symptomatic disease:
Differential diagnosis:
Potential complications requiring imaging surveillance:
Body habitus considerations:
By following this imaging algorithm, clinicians can accurately diagnose MALS, guide appropriate treatment decisions, and monitor for potential complications that may significantly impact patient morbidity and mortality.